Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: A meta-analysis

Tumor Biology

Volumn 34, Issue 2, 2013, Pages 901-907

  Zhang, Ri Chu ^a   Mou, Si Hua ^a  

^a TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; hOGG1; Meta analysis; Polymorphism; XPD

Indexed keywords

8 HYDROXYGUANINE GLYCOSYLASE 1; GLYCOSYLTRANSFERASE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN; DNA GLYCOSYLTRANSFERASE; ERCC2 PROTEIN, HUMAN; OXOGUANINE GLYCOSYLASE 1, HUMAN;

ARTICLE; CANCER RISK; DNA POLYMORPHISM; EXCISION REPAIR; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIVER CELL CARCINOMA; OGG1 GENE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; XPD GENE; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; META ANALYSIS; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

MLCS; MLOWN;

EID: 84877153395     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0625-7     Document Type: Article

References (36)

1. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer. 2007;96:1127-34.
2. Gao J, Xie L, Yang WS, Zhang W, Gao S, Wang J, et al. Risk factors of hepatocellular carcinoma - current status and perspectives. Asian Pac J Cancer Prev. 2012;13:743-52.
3. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002;17:463-9.
4. Shen M, Hung RJ, Brennan P, Malavielle C, Donato F, Placidi D, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposure, and bladder cancer risk in a case-control study in Northern Italy. Cancer Epidemiol Biomark Prev. 2003;12:1234-40.
5. Xu L, Wu Y, Jin Y, Yu Y, Qian G. A case-control study on polymorphism of DNA repair gene XPD and susceptibility to hepatocellular carcinoma. Tumor. 2004;24:526-9. in Chinese.
6. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, et al. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol. 2005;34:1310-8.
7. Xie W. Association between the nucleotide excision repair (NER) genes polymorphisms and genetic susceptibility and clinical phenotype of hepatocellular carcinoma. Doctoral Dissertation of Guangxi Medical University 2007; 1-103. in Chinese.
8. Long XD, Ma Y, Zhou YF, Yao JG, Ban FZ, Huang YZ, et al. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer. 2009;9:400.
9. Cui X, Su H. A case-control study on the polymorphism of gene XPD and the susceptibility of primary hepatic carcinoma. Med J Chin People's Health. 2010;22:912-4. in Chinese.
10. Gulnaz A, Sayyed AH, Amin F, Khan AU, Aslam MA, Shaikh RS, et al. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus. Eur J Gastroenterol Hepatol. 2012. doi: 10.1097/MEG.0b013e328359a775.
11. Hu H, Zhang C, Deng W, Huang Q, Dong X, Wang C, et al. Study on the familial aggregation factors of hepatocellular carcinoma. Yiyao Qianyan. 2012;2:143-4. in Chinese.
12. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys. 2000;377:1-8.
13. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog. 2005;42:127-41.
14. Zhang H, Hao B, He F. Studies on association between susceptibility of hepatocellular carcinoma and genetic polymorphism Ser326Cys of DNA repair gene hOGG1. Chin J Clin Oncol. 2005;32:841-3. in Chinese.
15. Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, et al. hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among Japanese. J Epidemiol. 2006;16:233-9.
16. Wang A, Cong W, He X, Jia H, Jin X, Zhu G, et al. A hOGG1 gene polymorphism and genetic susceptibility to colorectal cancer and hepatocellular carcinoma. Chin J Gastroenterol Hepatol. 2008;17:854-7. in Chinese.
17. Ji L, Zeng X, Li L, Chou X, Chen S, Yu H. Interaction between the single-nucleotide polymorphism of DNA repair gene hOGG1 and HBV infection and its susceptibility to hepatocellular carcinoma. J Hyg Res. 2011;40:705-8. in Chinese.
18. Tang G, Li X, Liu T, Yang J, Luo J, Liang Z. Genetic polymorphisms of DNA repair genes in patients with hepatocellular carcinoma. Shandong Med J. 2011;51:19-20. in Chinese.
19. Yuan T, Wei J, Luo J, Liu M, Deng S, Chen P. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk. Dig Dis Sci. 2012;57:2451-7.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
24. Yuan T, Deng S, Liu H, Liu M, Chen P. Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: a case-control study. Exp Ther Med. 2012;4:285-90.
25. Long XD, Ma Y, Zhou YF, Ma AM, Fu GH. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology. 2010;52:1301-9.
26. Mi Y, Zhang L, Feng N, Wu S, You X, Shao H, et al. Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer. PLoS One. 2012;7:e44756.
27. Zhu S, Zhang H, Tang Y, Wang J. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis. Urol Int. 2012;89:233-40.
28. Xue H, Lu Y, Lin B, Chen J, Tang F, Huang G. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PLoS One. 2012;7:e43431.
29. Li BR, Zhou GW, Bian Q, Song B. Lack of association between the hOGG1 Ser326Cys polymorphism and gastric cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:1145-9.
30. Duan XL, Gong H, Zeng XT, Ni XB, Yan Y, Chen W, et al. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:3299-303.
31. Yuan H, Niu YM, Wang RX, Li HZ, Chen N. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis. Genet Mol Res. 2011;10:3356-64.
32. Liu J, Cao XL, Zhang Z, Lei DP, Jin T, Yu XM, et al. HOGG1 Ser326Cys polymorphism and susceptibility to head and neck cancer: a meta-analysis. Asian Pac J Cancer Prev. 2011;12:2491-4.
33. Feng Z, Ni Y, Dong W, Shen H, Du J. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis. Mol Biol Rep. 2012;39:57-69.
34. Zhong D, Li G, Long J, Wu J, Hu Y. The hOGG1Ser326Cys polymorphism and increased lung cancer susceptibility in Caucasians: an updated meta-analysis. Sci Rep. 2012;2:548.
35. Pabalan N, Francisco-Pabalan O, Sung L, Jarjanazi H, Ozcelik H. Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer. Breast Cancer Res Treat. 2010;124:531-41.
36. Yuan W, Xu L, Feng Y, Yang Y, Chen W, Wang J, et al. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:835-42.